Jansen M, van Schaik FM, Ricker AT, Bullock B, Woods DE, Gabbay KH, Nussbaum AL, Sussenbach JS, Van den Brande JL (1983). "Sequence of cDNA encoding human insulin-like growth factor I precursor". Nature306 (5943): 609–11. PMID6358902. doi:10.1038/306609a0.
Guevara-Aguirre, J; .Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng CW, Hwang D, Martin-Montalvo A, Saavedra J, Ingles S, de Cabo R, Cohen P, Longo VD (2011-02-16). "Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans". Sci Transl Med.3 (70): 70ra13. PMID21325617. doi:10.1126/scitranslmed.3001845.
Pawlikowska, L; Hu D, Huntsman S, Sung A, Chu C, Chen J, Joyner AH, Schork NJ, Hsueh WC, Reiner AP, Psaty BM, Atzmon G, Barzilai N, Cummings SR, Browner WS, Kwok PY, Ziv E; Study of Osteoporotic Fractures (2019-08). "Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity". Sci Transl Med.8 (4): 460–72. PMID19489743. doi:10.1111/j.1474-9726.2009.00493.x.
Friedrich N, Schneider HJ, Haring R, Nauck M, Völzke H, Kroemer HK, Dörr M, Klotsche J, Jung-Sievers C, Pittrow D, Lehnert H, März W, Pieper L, Wittchen HU, Wallaschofski H, Stalla GK (2012). "Improved prediction of all-cause mortality by a combination of serum total testosterone and insulin-like growth factor I in adult men". Steroids77 (1-2): 52–8. PMID22037276. doi:10.1016/j.steroids.2011.10.005.
Scarth J (2006). "Modulation of the growth hormone-insulin-like growth factor (GH-IGF) axis by pharmaceutical, nutraceutical and environmental xenobiotics: an emerging role for xenobiotic-metabolizing enzymes and the transcription factors regulating their expression. A review". Xenobiotica36 (2–3): 119–218. PMID16702112. doi:10.1080/00498250600621627.
Rosenbloom AL (2007). "The role of recombinant insulin-like growth factor I in the treatment of the short child". Curr. Opin. Pediatr.19 (4): 458–64. PMID17630612. doi:10.1097/MOP.0b013e3282094126.
Fletcher L, Kohli S, Sprague SM, Scranton RA, Lipton SA, Parra A, Jimenez DF, Digicaylioglu M (2009). "Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation". J. Neurosurg.111 (1): 164–70. PMID19284235. doi:10.3171/2009.2.JNS081199.
Buckway CK, Wilson EM, Ahlsén M, Bang P, Oh Y, Rosenfeld RG (2001). "Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding". J. Clin. Endocrinol. Metab.86 (10): 4943–50. PMID11600567. doi:10.1210/jc.86.10.4943.
Cohen P, Graves HC, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG (1992). "Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma". J. Clin. Endocrinol. Metab.75 (4): 1046–53. PMID1383255. doi:10.1210/jc.75.4.1046.
Twigg SM, Baxter RC (1998). "Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit". J. Biol. Chem.273 (11): 6074–9. PMID9497324. doi:10.1074/jbc.273.11.6074.
Firth SM, Ganeshprasad U, Baxter RC (1998). "Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3". J. Biol. Chem.273 (5): 2631–8. PMID9446566. doi:10.1074/jbc.273.5.2631.
Qin X, Strong DD, Baylink DJ, Mohan S (1998). "Structure-function analysis of the human insulin-like growth factor binding protein-4". J. Biol. Chem.273 (36): 23509–16. PMID9722589. doi:10.1074/jbc.273.36.23509.
Ahmed S, Yamamoto K, Sato Y, Ogawa T, Herrmann A, Higashi S, Miyazaki K (2003). "Proteolytic processing of IGFBP-related protein-1 (TAF/angiomodulin/mac25) modulates its biological activity". Biochem. Biophys. Res. Commun.310 (2): 612–8. PMID14521955. doi:10.1016/j.bbrc.2003.09.058.
Jansen M, van Schaik FM, Ricker AT, Bullock B, Woods DE, Gabbay KH, Nussbaum AL, Sussenbach JS, Van den Brande JL (1983). "Sequence of cDNA encoding human insulin-like growth factor I precursor". Nature306 (5943): 609–11. PMID6358902. doi:10.1038/306609a0.
Salmon W, Daughaday W (1957). "A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro". J Lab Clin Med49 (6): 825–36. PMID13429201.
Miura, Y.; Kato, H.; Noguchi, T. (2007). "Effect of dietary proteins on insulin-like growth factor-1 (IGF-1) messenger ribonucleic acid content in rat liver". British Journal of Nutrition 67 (2): 257. doi:10.1079/BJN19920029. PMID 1596498.
Guevara-Aguirre, J; .Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng CW, Hwang D, Martin-Montalvo A, Saavedra J, Ingles S, de Cabo R, Cohen P, Longo VD (2011-02-16). "Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans". Sci Transl Med.3 (70): 70ra13. PMID21325617. doi:10.1126/scitranslmed.3001845.
Pawlikowska, L; Hu D, Huntsman S, Sung A, Chu C, Chen J, Joyner AH, Schork NJ, Hsueh WC, Reiner AP, Psaty BM, Atzmon G, Barzilai N, Cummings SR, Browner WS, Kwok PY, Ziv E; Study of Osteoporotic Fractures (2019-08). "Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity". Sci Transl Med.8 (4): 460–72. PMID19489743. doi:10.1111/j.1474-9726.2009.00493.x.
Vaught JL, Contreras PC, Glicksman MA, Neff NT (1996). "Potential utility of rhIGF-1 in neuromuscular and/or degenerative disease". Ciba Found. Symp.196: 18–27; discussion 27–38. PMID8866126.
Friedrich N, Schneider HJ, Haring R, Nauck M, Völzke H, Kroemer HK, Dörr M, Klotsche J, Jung-Sievers C, Pittrow D, Lehnert H, März W, Pieper L, Wittchen HU, Wallaschofski H, Stalla GK (2012). "Improved prediction of all-cause mortality by a combination of serum total testosterone and insulin-like growth factor I in adult men". Steroids77 (1-2): 52–8. PMID22037276. doi:10.1016/j.steroids.2011.10.005.
Scarth J (2006). "Modulation of the growth hormone-insulin-like growth factor (GH-IGF) axis by pharmaceutical, nutraceutical and environmental xenobiotics: an emerging role for xenobiotic-metabolizing enzymes and the transcription factors regulating their expression. A review". Xenobiotica36 (2–3): 119–218. PMID16702112. doi:10.1080/00498250600621627.
Ranges estimated from quantile regression as shown in table 4 in: Friedrich, N.; Alte, D.; Volzke, H.; Spilckeliss, E.; Ludemann, J.; Lerch, M.; Kohlmann, T.; Nauck, M. et al (2008). "Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: Results of the Study of Health in Pomerania (SHIP)". Growth Hormone & IGF Research 18 (3): 228–237. doi:10.1016/j.ghir.2007.09.005. PMID 17997337.
Rosenbloom AL (2007). "The role of recombinant insulin-like growth factor I in the treatment of the short child". Curr. Opin. Pediatr.19 (4): 458–64. PMID17630612. doi:10.1097/MOP.0b013e3282094126.
Fletcher L, Kohli S, Sprague SM, Scranton RA, Lipton SA, Parra A, Jimenez DF, Digicaylioglu M (2009). "Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation". J. Neurosurg.111 (1): 164–70. PMID19284235. doi:10.3171/2009.2.JNS081199.
Buckway CK, Wilson EM, Ahlsén M, Bang P, Oh Y, Rosenfeld RG (2001). "Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding". J. Clin. Endocrinol. Metab.86 (10): 4943–50. PMID11600567. doi:10.1210/jc.86.10.4943.
Cohen P, Graves HC, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG (1992). "Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma". J. Clin. Endocrinol. Metab.75 (4): 1046–53. PMID1383255. doi:10.1210/jc.75.4.1046.
Twigg SM, Baxter RC (1998). "Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit". J. Biol. Chem.273 (11): 6074–9. PMID9497324. doi:10.1074/jbc.273.11.6074.
Firth SM, Ganeshprasad U, Baxter RC (1998). "Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3". J. Biol. Chem.273 (5): 2631–8. PMID9446566. doi:10.1074/jbc.273.5.2631.
Bach LA, Hsieh S, Sakano K, Fujiwara H, Perdue JF, Rechler MM (1993). "Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6". J. Biol. Chem.268 (13): 9246–54. PMID7683646.
Qin X, Strong DD, Baylink DJ, Mohan S (1998). "Structure-function analysis of the human insulin-like growth factor binding protein-4". J. Biol. Chem.273 (36): 23509–16. PMID9722589. doi:10.1074/jbc.273.36.23509.
Ahmed S, Yamamoto K, Sato Y, Ogawa T, Herrmann A, Higashi S, Miyazaki K (2003). "Proteolytic processing of IGFBP-related protein-1 (TAF/angiomodulin/mac25) modulates its biological activity". Biochem. Biophys. Res. Commun.310 (2): 612–8. PMID14521955. doi:10.1016/j.bbrc.2003.09.058.